King C. Yabut

Pharmacology, Toxicology and PharmaceuticsBiochemistry, Genetics and Molecular BiologyEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Analysis of vitamin A and retinoids in biological matrices”.

Analysis of vitamin A and retinoids in biological matrices

Methods in enzymology on CD-ROM/Methods in enzymology(2020)10.1016/bs.mie.2020.02.010

N/A

0DataRank · unranked

25 citations

Guo Zhong, King C. Yabut, Nina Isoherranen, Lindsay C. Czuba

CRABPs Alter all-trans-Retinoic Acid Metabolism by CYP26A1 via Protein-Protein Interactions

Nutrients(2022)10.3390/nu14091784

N/A

0DataRank · unranked

29 citations

Nina Isoherranen, King C. Yabut

Impact of Intracellular Lipid Binding Proteins on Endogenous and Xenobiotic Ligand Metabolism and Disposition

Drug Metabolism and Disposition(2023)10.1124/dmd.122.001010

N/A

0DataRank · unranked

22 citations

Nina Isoherranen, King C. Yabut

CYP2C9, CYP3A and CYP2C19 metabolize Δ9-tetrahydrocannabinol to multiple metabolites but metabolism is affected by human liver fatty acid binding protein (FABP1)

Biochemical Pharmacology(2024)10.1016/j.bcp.2024.116191

N/A

0DataRank · unranked

21 citations

Yue Winnie Wen, Keiann T. Simon, Nina Isoherranen, King C. Yabut

Drugs Form Ternary Complexes with Human Liver Fatty Acid Binding Protein 1 (FABP1) and FABP1 Binding Alters Drug Metabolism

Molecular Pharmacology(2024)10.1124/molpharm.124.000878

N/A

0DataRank · unranked

9 citations

Alice Martynova, Abhinav Nath, Benjamin P. Zercher, Matthew F. Bush, Nina Isoherranen +1 more